| 16.35 1.4 (9.36%) | 01-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Bright Health Group, Inc., headquartered in Minneapolis, Minnesota, is a healthcare enterprise providing both health insurance and direct care services across the United States. The company operates through two primary divisions. Its NeueHealth segment is dedicated to delivering clinical care, both virtually and in person, via its network of owned and affiliated primary care clinics under contractual arrangements. By the close of 2021, this integrated care delivery system had established collaborations with roughly 260,000 care provider partners and managed 180 affiliated risk-bearing clinics, which incorporated on-site pharmacy, laboratory, radiology, and specialized population health services. Concurrently, the Bright HealthCare segment offers commercial and Medicare health plans to individuals across 14 states and 99 distinct markets. Initially incorporated in 2015, the company adopted its current name, Bright Health Group, Inc., in February 2021, having previously been known as Bright Health Inc.
Tue, 01 Sep 2026
Bright Health Group Inc (BHG) Peer Comparison – Compare with Others - Value Research
Tue, 01 Sep 2026
Bright Health Group Inc (BHG) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Thu, 18 Jan 2024
Bright Health Group moves headquarters to Florida, changes name to NeueHealth - The Business Journals
Thu, 15 Jun 2023
Bright Health downgraded at Barclays on liquidity, Medicare MLR pressure (NYSE:BHG) - Seeking Alpha
Wed, 24 May 2023
Florence acquires Zipnosis from Bright Health in all-cash deal - Axios
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|